首页   按字顺浏览 期刊浏览 卷期浏览 SIZE REDUCTION OF A PROLACTIN SECRETING ADENOMA DURING LONG‐TERM TREATMENT WITH THE DOP...
SIZE REDUCTION OF A PROLACTIN SECRETING ADENOMA DURING LONG‐TERM TREATMENT WITH THE DOPAMINE AGONIST LISURIDE

 

作者: P. G. CHIODINI,   A. LIUZZI,   G. VERDE,   R. COZZI,   F. SILVESTRINI,   M. T. MARSILI,   R. HOROWSKI,   F. PASSERINI,   G. LUCCARELLI,   P. G. BORGHI,  

 

期刊: Clinical Endocrinology  (WILEY Available online 1980)
卷期: Volume 12, issue 1  

页码: 47-51

 

ISSN:0300-0664

 

年代: 1980

 

DOI:10.1111/j.1365-2265.1980.tb03131.x

 

出版商: Blackwell Publishing Ltd

 

数据来源: WILEY

 

摘要:

SUMMARYA 38–year‐old amenorrhoeic woman suffering from a prolactin (PRL) secreting adenoma, which had suprasellar extension as shown by carotid angiography and computed axial tomography (CAT), was treated with a dopamine agonist (lisuride). PRL levels were lowered and after 1 year of treatment CAT showed a marked reduction of the tumour size. After 2 years of treatment menstruation returned and CAT demonstrated a further reduction of the adenomatous tissue. This study supports the suggestion that dopamine agonists possess an anti‐pro‐liferative effect on tumoural lactotrophic cells of

 

点击下载:  PDF (877KB)



返 回